DC
Dandu Chakradhar
About Dandu Chakradhar
Data last updated:
Dandu Chakradhar is a Director at Escientia Advanced Sciences Private Limited (since 2020), Director at Escientia Biopharma Private Limited (since 2020) and Director at Deccan Advanced Sciences Private Limited (since 2020). The companies operate in Pharma and Life Sciences. The 3 current companies with reported revenue have a combined latest revenue of ₹443 Cr; the largest is Escientia Advanced Sciences Private Limited at ₹423 Cr (FY 2024). Earlier, Dandu Chakradhar was a Director at Zapforce Technologies Private Limited (from 2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Escientia Advanced Sciences Private Limited U24100TG2013PTC085962 | Director | 19 Aug 2020 | 2013 | ₹423 Cr (FY 2024) | Active |
| Escientia Biopharma Private Limited U24100TG2008PTC057277 | Director | 19 Aug 2020 | 2008 | ₹20.04 Cr (FY 2025) | Active |
 Deccan Advanced Sciences Private Limited U74999TG2020PTC142323 | Director | 30 Jul 2020 | 2020 | ₹11.9 Lakh (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Zapforce Technologies Private Limited U74900KA2015PTC080918 | Director | 29 Apr 2016 | 2015 | ₹94.9 Lakh (FY 2017) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Dandu Chakradhar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dandu Chakradhar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dandu Chakradhar
Dandu Chakradhar currently holds 3 directorships: Escientia Advanced Sciences Private Limited (Director, since 19 Aug 2020, revenue ₹423 Cr (FY 2024)); Escientia Biopharma Private Limited (Director, since 19 Aug 2020, revenue ₹20.04 Cr (FY 2025)); Deccan Advanced Sciences Private Limited (Director, since 30 Jul 2020, revenue ₹11.9 Lakh (FY 2023)).
Dandu Chakradhar was first appointed on 29 Apr 2016 as Director at Zapforce Technologies Private Limited. The most recent appointment on record is 19 Aug 2020 at Escientia Biopharma Private Limited.
The 3 current companies of Dandu Chakradhar that report revenue have a combined latest revenue of ₹443 Cr: Escientia Advanced Sciences Private Limited ₹423 Cr (FY 2024); Escientia Biopharma Private Limited ₹20.04 Cr (FY 2025); Deccan Advanced Sciences Private Limited ₹11.9 Lakh (FY 2023).
Dandu Chakradhar held 1 earlier board appointment: Zapforce Technologies Private Limited (Director, from 29 Apr 2016).
The current boards of Dandu Chakradhar's companies include Ajit Alexander George (Escientia Advanced Sciences Private Limited), Pendri Kiran Reddy (Escientia Advanced Sciences Private Limited), Srinivasa Rao Korada (Escientia Advanced Sciences Private Limited), Srinivasa Rao Korada (Escientia Advanced Sciences Private Limited), Vivek Vasant Save (Escientia Advanced Sciences Private Limited), Yadagiri R Pendri (Escientia Advanced Sciences Private Limited), among others.